Gainers
- OptiNose OPTN shares moved upwards by 9.81% to $1.79 during Monday's after-market session. Trading volume for this security closed at 71.3K, accounting for 17.16% of its average full-day volume over the last 100 days. The company's market cap stands at $147.1 million.
- Aileron Therapeutics ALRN shares moved upwards by 8.45% to $0.59. The market value of their outstanding shares is at $53.4 million.
- Abeona Therapeutics ABEO shares rose 6.28% to $0.34. Trading volume for this security closed at 149.9K, accounting for 6.83% of its average full-day volume over the last 100 days. The company's market cap stands at $49.8 million.
- Evoke Pharma EVOK stock rose 5.34% to $0.65. The company's market cap stands at $21.2 million.
- Eloxx Pharmaceuticals ELOX stock moved upwards by 4.1% to $0.76. The company's market cap stands at $65.5 million.
- BioLine Rx BLRX stock moved upwards by 3.55% to $2.19. The company's market cap stands at $104.1 million.
Losers
- China SXT Pharmaceuticals SXTC stock declined by 6.7% to $0.53 during Monday's after-market session. The market value of their outstanding shares is at $8.2 million.
- Alterity Therapeutics ATHE shares declined by 4.17% to $0.76. The market value of their outstanding shares is at $30.4 million.
- Microbot Medical MBOT shares fell 3.36% to $8.65. This security traded at a volume of 1.0 million shares come close, making up 2492.78% of its average volume over the last 100 days. The market value of their outstanding shares is at $61.4 million.
- Annovis Bio ANVS stock declined by 2.81% to $19.41. The market value of their outstanding shares is at $157.2 million.
- Dare Bioscience DARE stock declined by 1.91% to $2.06. The company's market cap stands at $157.7 million.
- Rockwell Medical RMTI stock declined by 1.85% to $0.37. The company's market cap stands at $35.0 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in